COMPANY

The drug candidates to increase the success rate Leading Research and Development company for the discovery of optimal novel drug candidates and repurposing of novel drugs using orthotopic model-based clinical translational research

Company name
PLATBIO Inc.
CEO
KIM SUN JIN
Est.
2018.08.03.
Major business
New drug R&D/ Consulting/ Research service
Head office
#1501, Ace Gwanggyo Tower 2, 91, Changnyong-daero 256 beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
Homepage
www.platbio.com
  • Orthotopic Animal Model,
    Clinical Translational Research
    Orthotopic Animal Model & Clinical Translational Research Enabling accurate pre-clinical trials with world class orthotopic model and clinical translational research capability
  • Increasing the
    Success Rate of
    Clinical Trials
    Higher success rate of
    clinical trials from scientifically
    accurate pre-clinical data
  • Largest Number of Novel Anticancer Targets
    in Korea
    50 novel targets from pancreatic
    cancer and ovarian cancer and expanding the target list from other indications
  • Global
    Network
    Broad and Deep connections with global big pharmas to enable bigger license- out deals